IFNB1 and neoplasm: As a proof-of-principle, in a xenogeneic experimental model, human iPSC-derived myeloid cell lines engineered to overexpress IFNB or IFNA and to maintain their proliferative activity accumulated within neoplastic lesions and inhibited human tumor growth [30,31,32,33].